EFA co-signs letter to environment ministers for swift implementation of new EU air quality rules
On October 7th, EFA along its allies in the EU Healthy Air Coalition united their voice in a letter addressed to the EU environment ministers. Published...
Immuniverse Annual Progress Meeting: bringing atopic eczema patients voices in research
On September 30 and October 1, the Immuniverse Annual Progress Meeting took place in Frankurt, Germany. The event marked a significant moment for the Immuniverse...
EFA re-elected at HEAL AGA 2024: protecting health and the environment in Europe
EFA joined the Health and Environment Alliance (HEAL) Annual General Assembly on October 1-2 in Brussels, represented by EFA Senior Policy Advisor Panagiotis...
EFA Community brings patient voices to the EADV Congress 2024!
From September 25-28 in Amsterdam, #EFACommunity joined forces at the annual EADV Congress, representing the voices of atopic eczema patients across Europe....
TOLIFE project General Assembly: advancing COPD patient-centric care through AI and collaboration
On September 25 and 26, EFA participated in the General Assembly of the TOLIFE project in Madrid. EFA has been part of the initiative since 2022,...
EFA co-signs EU4Health Civil Society Alliance letter towards President Von der Leyen for a strong health policy in the new mandate
In a letter addressed to the Commission President Ursula von der Leyen, the EU4Health Civil Society Alliance (CSA) joined their voice calling for keeping...
Commission recommends far-reaching updates to country policies on smoke-free environments
After months of delay, on 17 September the Commission presented an updated Council recommendation on Smoke- and Aerosol-Free Environments. The non-legislative...
The Commission adopts new F-Gases labelling rules for MDIs
New EU rules on F-Gases could impact metered dose inhalers (MDIs), crucial for asthma and COPD patients, by treating them like ordinary products. EFA has...
World Atopic Eczema Day 2024: the #AtopicEczemaUnfiltered reality of patients
On 14 September, World Atopic Eczema Day, patient communities around the world are coming together to raise awareness on the burden of atopic eczema, also...
EFA Community advocates for better lives for asthma and COPD patients at ERS Congress 2024
During 7-11 September, EFA participated in the European Respiratory Society (ERS) Congress 2024, held in Vienna, Austria. Our strong delegation, including...
EFA President Marcia Podestà speaks at GA2LEN Anaphylaxis and Food Allergy Forum 2024
On 5 September, the President of EFA and Food Allergy Italia Marcia Podestà, was a speaker at a scientific workshop, part of the GA2LEN Anacare Anaphylaxis...
The EU Healthy Air Coalition calls for stronger clean air measures in the EU
On the occasion of the International of Clean Air for Blue Skies on 7 September, EFA joined forces with its partners within the EU Healthy Air Coalition...
EFA joins a new EU4Health project: LungHealth4Life (LH4L)
EFA is thrilled to join the LungHealth4Life (LH4L) project aiming to boost lung health through early intervention in schools across Europe. Leading the...
EFA Project: COPD Standards of Care – Raising the bar!
Shaping the Future of COPD Care: From Minimum to Optimal
A Call to Action to Stop Ignoring a Silent Disease Impacting Millions
Imagine coughing...
EFA and our Belgian members - Astma en Allergiekoepel, discuss Indoor Air Quality plans with the Belgian Ministry of Health
On 27 June, EFA and our Belgian member association - Astma en Allergiekoepel (AAK) had a joint meeting with the Belgian Federal Ministry of Health's Indoor...
EFA co-signs letter to Von der Leyen calling for Vice-President for Health, Wellbeing and Social Rights
In July, together with our partners from the EU4Health Civil Society Alliance (CSA), EFA co-signed a letter addressed to the President of the European...
Annual Report 2023: an overview of the patients agenda for allergy and airways diseases
Our Annual Report 2023 reflects a year of dedication and progress in improving the lives of respiratory patients in Europe. EFA has launched a new programmatic...
EFA responds to the HTA consultation on the cooperation with the EMA
EFA has actively engaged in the EU Health Technology Assessment (HTA) consultation, emphasising the importance of collaboration between HTA bodies and...
EFA calls for strong patient involvement in EU Health Technology Assessments
EFA has responded to another proposal for legislation completing the EU Health Technology Assessment Regulation (HTAR) that will determine how individual...
EFA attends the EU Partnership for the Assessment of Risks from Chemicals (PARC) forum
EFA participated in the 3rd Stakeholder Forum meeting of the Partnership for the Assessment of Risk from Chemicals (PARC), the EU-funded project advancing...